Skip to main content
. 2024 Dec 19;17:6367–6376. doi: 10.2147/IJGM.S496996

Table 1.

Comparison of Baseline Data

Control (n=51) Observation (n=52) t/x² P
Gender 0.318 0.572
 Male 41 (80.39%) 44 (84.62%)
 Female 10 (19.61%) 8 (15.38%)
Age (years) 48.64±9.85 (45.94, 51.34) 47.96±9.97 (45.25, 50.67) 0.348 0.728
BMI (kg/m²) 24.26±1.91 (23.73, 24.79) 24.07±2.02 (23.51, 24.63) 0.490 0.625
Onset to Intervention Time (h) 6.15±5.87 (4.51,7.79) 5.93±6.02 (4.27,7.59) 0.187 0.851
SBP (mmHg) 120.15±17.26 (115.34,125.00) 119.42±15.97 (115.01,123.83) 0.222 0.824
DBP (mmHg) 76.34±15.38 (72.05, 80.63) 74.96±16.03 (70.52, 79.40) 0.445 0.656
Comorbidities
 Hypertension 19 (37.25%) 21 (40.38%) 0.106 0.744
 Diabetes 6 (11.76%) 8 (15.38%) 0.287 0.592
Myocardial Infarction Site 0.083 0.772
 Anterior Wall 39 (76.47%) 41 (78.85%)
 Inferior Wall 12 (23.53%) 11 (21.15%)
Stents Implanted (number) 1.78±0.92 (1.524, 2.036) 1.83±0.89 (1.584, 2.076) 0.280 0.779